CJC-1295 + Ipamorelin
Research Peptide Blend — Solo para investigación
CJC-1295 + Ipamorelin is a research combination of modified GRF 1-29 (CJC-1295, CAS 863288-34-0) and ipamorelin (CAS 170851-70-4). These peptides engage distinct receptor pathways in laboratory signaling models. Compuesto para investigación — not for human use.
Detalles del producto
- Compuesto: CJC-1295 (No DAC) + Ipamorelin
- Contents: Modified GRF 1-29 and Ipamorelin
- Pruebas: Batch PP2602 passed Panda internal quality screening and is with Janoshik Analytical for formal third-party testing
- Forma: Polvo liofilizado
- Size: 10mg total (5mg + 5mg)
📚 Ver investigación publicada sobre CJC-1295 + Ipamorelin →
Citas revisadas por pares de PubMed, solo con fines educativos
CJC-1295 + Ipamorelin documentation path
This blend listing separates component identity, vial composition, and batch documentation so researchers can review the materials without relying on protocol-style claims.
- Composition: modified GRF 1-29 / CJC-1295 component plus Ipamorelin component.
- Documentation: review available COA records y Calidad y pruebas.
- Literature context: see CJC-1295 + Ipamorelin research y Ipamorelin research.
Research use only. This page does not provide dosing, administration, reconstitution, treatment, hormone-use, or human-use guidance.



